Correspondence 0001493152-24-020978 from GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)
GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)
Date: May 22, 2024 · CIK: 0001166272 · Accession: 0001493152-24-020978
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
May
22, 2024
Via
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
Re:
GENETIC
TECHNOLOGIES LIMITED (the “Company”)
Registration
Statement on Form F-1
File
No. 333- 279523 (the “Registration Statement”)
Ladies
and Gentlemen:
The
Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness
of the Registration Statement so that such Registration Statement will become effective as of 5.00 p.m. (Eastern Time) on May 24, 2024,
or as soon thereafter as practicable.
Please
contact Darrin M. Ocasio, Esq. of Sichenzia Ross Ference Carmel LLP counsel of the Company, at (212) 930-9700 to provide notice of effectiveness,
or if you have any questions or concerns regarding the foregoing.
Very
truly yours,
Genetic
Technologies Limited
By:
/s/
Simon Morriss
Name:
Simon
Morriss
Title:
Chief
Executive Officer
cc:
Darrin M. Ocasio, Esq.